Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis

This publication has 19 references indexed in Scilit:

• Protective Effect of a Tuberculosis Subunit Vaccine Based on a Fusion of Antigen 85B and ESAT-6 in the Aerosol Guinea Pig Model
  Infection and Immunity, 2004
• Enhanced Protection against Tuberculosis by Vaccination with RecombinantMycobacterium microtiVaccine That Induces T Cell Immunity against Region of Difference 1 Antigens
  The Journal of Infectious Diseases, 2004
• Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis
  Nature Medicine, 2003
• Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids
  Infection and Immunity, 2002
• Protective Immunity againstMycobacterium tuberculosisInduced by Dendritic Cells Pulsed with both CD8⁺- and CD4⁺-T-Cell Epitopes from Antigen 85A
  Infection and Immunity, 2002
• Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting
  Infection and Immunity, 2001
• Identification of a Mycobacterium bovis BCG Auxotrophic Mutant That Protects Guinea Pigs against M. bovis and Hematogenous Spread of Mycobacterium tuberculosis without Sensitization to Tuberculin
  Infection and Immunity, 2000
• Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing theMycobacterium tuberculosis30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model
  Proceedings of the National Academy of Sciences, 2000
• Comparison of the Protective Efficacy of Bacille Calmette-Guérin Vaccination against Aerosol Challenge with Mycobacterium tuberculosis and Mycobacterium bovis
  Clinical Infectious Diseases, 2000
• Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
  Nature, 1998